|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2018 11:59AM
|
|
Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 05:33PM
|
|
Re: Bioasis board very quiet with a flat share price
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2021 09:27AM
|
|
Re: Bioasis board very quiet with a flat share price
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2021 12:25PM
|
|
Re: Bioasis Vs Annexon Inc.
|
|
BIOASIS TECHNOLOGIES INC
|
Sep 15, 2022 09:48AM
|
|
Re: BRD4 inhibition and PARP Inhibition
|
3
|
Zenith Epigenetics
|
Mar 14, 2018 03:53PM
|
|
Re: Breaking Down Barriers: BiOasis Technologies Promises Breakthrough Brain Drug Delivery
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 19, 2018 03:59PM
|
|
Re: Buying the dip.....
|
|
Resverlogix Corp.
|
Jun 12, 2017 11:52AM
|
|
Re: Buyouts - Share Marketability
|
3
|
Zenith Epigenetics
|
Jul 01, 2016 06:01PM
|
|
Re: Can't access the Zacks reports anymore?
|
3
|
BIOASIS TECHNOLOGIES INC
|
Apr 07, 2021 01:03PM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
5
|
Zenith Epigenetics
|
Jan 30, 2019 12:14PM
|
|
Re: Checklist: Desired Response
|
3
|
Resverlogix Corp.
|
Aug 02, 2016 04:32PM
|
|
Re: Chinese Takeovers
|
3
|
Zenith Epigenetics
|
Mar 07, 2018 10:32AM
|
|
Re: citi LoC
|
4
|
Resverlogix Corp.
|
Feb 06, 2017 05:34PM
|
|
Re: citi LoC
|
3
|
Resverlogix Corp.
|
Feb 06, 2017 10:43PM
|
|
Re: CityNews cover
|
3
|
Resverlogix Corp.
|
Jan 31, 2022 12:45PM
|
|
Re: CityNews cover
|
4
|
Resverlogix Corp.
|
Jan 31, 2022 01:13PM
|
|
Re: Clinical trials query results
|
2
|
Zenith Epigenetics
|
Apr 08, 2021 10:23AM
|
|
Re: Close competitor…
|
6
|
Resverlogix Corp.
|
Oct 19, 2021 05:45PM
|
|
Re: Competition
|
5
|
Resverlogix Corp.
|
Nov 29, 2021 12:47PM
|
